Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation

Cancer

Volumn 115, Issue 21, 2009, Pages 4959-4972

  Li, Ming ^a,b   Wang, Jide ^c   Ng, Samuel S M ^a   Chan, Chu Yan ^d   He, Ming Liang ^d   Yu, Fang ^a   Lai, Lihui ^e   Shi, Chao ^a   Chen, Yangchao ^d   Yew, David T ^d   Kung, Hsiang Fu ^d   Lin, Marie Chia Mi ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FIRST MILITARY MEDICAL UNIVERSITY   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Adenosine diphosphate ribosylation factor 6; Epidermal growth factor; Glioma; Signaling pathway; SP1

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; DACTINOMYCIN; EPIDERMAL GROWTH FACTOR; JANUS KINASE 2; MESSENGER RNA; MITHRAMYCIN; MITHRAMYCIN A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DISEASE SEVERITY; DNA FLANKING REGION; DOSE RESPONSE; DRUG TARGETING; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ADP-RIBOSYLATION FACTORS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; GLIOBLASTOMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR;

EID: 70350501255     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24550     Document Type: Article

References (40)

1. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215-225. (Pubitemid 34212595)
2. Raizer JJ. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme. J Neurooncol. 2005; 74:77-86.
3. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996. (Pubitemid 40349501)
4. Watanabe K, Tachibana O, Sata K, et al. Over-expression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 1996;6:217-223. (Pubitemid 26246377)
5. Wong AJ, Ruppert JM, Bigner SH, et al. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A. 1992;89:2965-2969.
6. Thomas CY, Chouinard M, Cox M, et al. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. Int J Cancer. 2003; 104:19-27. (Pubitemid 36184143)
7. Aldape KD, Ballman K, Furth A, et al. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J Neuropathol Exp Neurol. 2004;63:700-707. (Pubitemid 38891086)
8. Li B, Yuan M, Kim IA, et al. Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin. Oncogene. 2004; 23:4594-4602. (Pubitemid 38850407)
9. Donaldson JG. Multiple roles for ARF6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem. 2003;278:41573-41576. (Pubitemid 37310409)
10. Gaschet J, Hsu VW. Distribution of ARF6 between membrane and cytosol is regulated by its GTPase cycle. J Biol Chem. 1999;274:20040-20045.
11. Frank S, Upender S, Hansen SH, et al. ARNO is a guanine nucleotide exchange factor for ADP-ribosylation factor 6. J Biol Chem. 1998;273:23-27. (Pubitemid 28042170)
12. Palacios F, Price L, Schweitzer J, et al. An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J. 2001; 20:4973-4986.
13. Zhang Q, Calafat J, Janssen H, et al. ARF6 is required for growth factor- and rac-mediated membrane ruffling in macrophages at a stage distal to rac membrane targeting. Mol Cell Biol. 1999;19:8158-8168. (Pubitemid 30414010)
14. Bornancin F, Audigier Y, Chabre M. ADP-ribosylation of Gs by cholera toxin is potentiated by agonist activation of beta-adrenergic receptors in the absence of GTP. J Biol Chem. 1993;268:17026-17029. (Pubitemid 23236928)
15. Li M, Ng SS, Wang J, et al. EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling. Cancer Res. 2006;66:1583-1590. (Pubitemid 43259941)
16. Altschuler Y, Liu S, Katz L, et al. ADP-ribosylation factor 6 and endocytosis at the apical surface of Madin-Darby canine kidney cells. J Cell Biol. 1999;147:7-12. (Pubitemid 30211791)
17. Fry DW, Kraker AJ, McMichael A, et al. A specific inhibitor of epidermal growth factor receptor tyrosine kinase. Science. 1994;265:1093-1095. (Pubitemid 24293076)
18. Wells A. EGF receptor. Int J Biochem Cell Biol. 1999; 31:637-643.
19. Lebeda RA, Johnson SK, Stewart MI, et al. Sequence, genomic organization, and expression of the human ADP-ribosylation factor 6 (ARF6) gene: a class III ARF. DNA Cell Biol. 2003;22:737-741.
20. Blume SW, Snyder RC, Ray R, et al. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest. 1999;88:1613-1621.
21. Alroy I, Soussan L, Seger R, et al. Neu differentiation factor stimulates phosphorylation and activation of the SP1 transcription factor. Mol Cell Biol. 1999;19:1961-1972. (Pubitemid 29098254)
22. Reisinger K, Kaufmann R, Gille J. Increased SP1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J Cell Sci. 2003;116:225-238.
23. OudeWeernink PA, Verheul E, Kerkhof E, et al. Inhibitors of protein tyrosine phosphorylation reduce the proliferation of 2 human glioma cell lines. Neurosurgery. 1996;38:108-113.
24. Moscatello DK, Holgado-Madruga M, Emlet DR, et al. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem. 1998;273:200-206. (Pubitemid 28042194)
25. Narita Y, Nagane M, Mishima K, et al. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res. 2002;62:6764-6769.
26. Prigent SA, Nagane M, Lin H, et al. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras- Shc-Grb2 pathway. J Biol Chem. 1996;271:25639-25645. (Pubitemid 26337944)
27. Klingler-Hoffmann M, Bukczynska P, Tiganis T. Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells. Int J Cancer. 2003;105:331-339. (Pubitemid 36570045)
28. Choe G, Horvath S, Cloughesy TF, et al. Analysis of the phosphatidylinositol 30-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res. 2003;63:2742-2746. (Pubitemid 36667143)
29. Klingler-Hoffmann M, Fodero-Tavoletti MT, Mishima K, et al. The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor. J Biol Chem. 2001;276: 46313-46318. (Pubitemid 33646909)
30. Ikeda S, Ushio-Fukai M, Zuo L, et al. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res. 2005;96:467-475. (Pubitemid 40354541)
31. Dikic I, Giordano S. Negative receptor signaling. Curr Opin Cell Biol. 2003;15:128-135.
32. Benmerah A. Endocytosis: signaling from endocytic membranes to the nucleus. Curr Biol. 2004;14:R314-316. (Pubitemid 38503596)
33. Waterman H, Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Lett. 2001;490:142-152. (Pubitemid 32171933)
34. Lanzetti L, Rybin V, Malabarba MG, et al. The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature. 2000;408:374-377.
35. Ceresa BP, Bahr SJ. Rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome. J Biol Chem. 2006;281:1099-1106.
36. Alexander A. Endocytosis and intracellular sorting of receptor tyrosine kinases. Front Biosci. 1998;3:d729-738.
37. Nie Z, Hirsch DS, Randazzo PA. Arf and its many interactors. Curr Opin Cell Biol. 2003;15:396-404.
38. Krauss M, Kinuta M, Wenk MR, et al. ARF6 stimulates clathrin/AP-2 recruitment to synaptic membranes by activating phosphatidylinositol phosphate kinase type Igamma. J Cell Biol. 2003;162:113-124.
39. Paleotti O, Macia E, Luton F, et al. The small G-protein ARF6GTP recruits the AP-2 adaptor complex to membranes. J Biol Chem. 2005;280:21661-21666. (Pubitemid 40805736)
40. Houndolo T, Boulay PL, Claing A. G protein-coupled receptor endocytosis in ADP-ribosylation factor 6-depleted cells. J Biol Chem. 2005;280:5598-5604 (Pubitemid 40280038)